Sanofi
SNYNF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | – | $3,940,000 | $0 | $683,000 |
| Dep. & Amort. | – | $0 | $0 | $0 |
| Deferred Tax | – | $0 | $0 | $0 |
| Stock-Based Comp. | – | $171,000 | $0 | $0 |
| Change in WC | – | $0 | $0 | $0 |
| Other Non-Cash | – | -$4,111,000 | $2,093,000 | -$683,000 |
| Operating Cash Flow | – | $0 | $2,093,000 | $0 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | – | $0 | $0 | $0 |
| Net Acquisitions | – | $0 | $0 | $0 |
| Inv. Purchases | – | $0 | $0 | $0 |
| Inv. Sales/Matur. | – | $0 | $0 | $0 |
| Other Inv. Act. | – | $0 | -$776,000 | $0 |
| Investing Cash Flow | – | $0 | -$776,000 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | – | $0 | $0 | $0 |
| Stock Issued | – | $0 | $0 | $0 |
| Stock Repurch. | – | $0 | $0 | $0 |
| Dividends Paid | – | $0 | $0 | $0 |
| Other Fin. Act. | – | $0 | -$592,000 | $0 |
| Financing Cash Flow | – | $0 | -$592,000 | $0 |
| Forex Effect | – | $0 | -$20,000 | $0 |
| Net Chg. in Cash | – | $0 | $550,000 | $0 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | – | $0 | $7,441,000 | $0 |
| End Cash | – | $0 | $7,991,000 | $0 |
| Free Cash Flow | – | $0 | $2,093,000 | $0 |